|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Regulus Therapeutics (NASDAQ: RGLS) through any online brokerage.
The latest price target for Regulus Therapeutics (NASDAQ: RGLS) was reported by HC Wainwright & Co. on 2020-05-04. The analyst firm set a price target for 1.50 expecting RGLS to rise to within 12 months (a possible 63.92% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Regulus Therapeutics (NASDAQ: RGLS) is $0.9151 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Regulus Therapeutics.
There is no upcoming split for Regulus Therapeutics.